Cumulus Neuroscience appoints Siggi Saevarsson as COO
BELFAST, Northern Ireland, Feb. 10, 2022 /PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), a leading global innovator providing real-world clinical trial data and AI-powered insights
Stay updated with breaking news from Ronan Cunningham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BELFAST, Northern Ireland, Feb. 10, 2022 /PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), a leading global innovator providing real-world clinical trial data and AI-powered insights
/PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), a leading global innovator providing real-world clinical trial data and AI-powered insights to...
/PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), a leading global innovator providing real-world clinical trial data and AI-powered insights to...
Funds will be used to advance company's integrated physiological and digital biomarker platform - News - PharmaTimes
‘Fitbit for the brain’ Cumulus raises £6m for its neuroscience headset Image: © jalisko/Stock.adobe.com The Belfast start-up will use the funds to expand development of its technology for gathering and analysing data for clinical trials. Belfast-based start-up Cumulus Neuroscience, which is developing a ‘Fitbit for the brain’, has raised £6m. The start-up, previously known as BrainWaveBank, is building an electroencephalogram (EEG) headset and AI-powered software to analyse brain activity and develop therapies for the central nervous system. The funding was led by Dementia Discove...